جست‌وجوی استاد و پژوهشگر

Christine P. Hendonمشاهده پروفایل

دانشیار

• Biomedical Optics
• Optical Coherence Tomography
• Near Infrared Spectroscopy
• +۷ مورد دیگر

Christine P. Hendon is an Associate Professor of Electrical Engineering at Columbia University's School of Engineering and Applied Science, where she also serves as Vice Dean for Engagement and Provost's Senior Faculty Teaching Scholar. She directs the Structure-Function Imaging Laboratory, which develops biomedical optics technologies for clinical applications. Her research focuses on developing optical coherence tomography (OCT) and near infrared spectroscopy (NIRS) systems for structure-function analysis of biological tissues, with particular emphasis on cardiac electrophysiology applications. The laboratory creates integrative optics and therapeutic probes to improve treatment of cardiac arrhythmias, developing platform optical imaging systems to enable structure-function analysis of biological organ systems. Professor Hendon's recent publications show expansion into women's health applications, with work on uterine tissue mechanics. Her research consistently bridges engineering innovation with clinical practice through collaborations with medical professionals. Presidential Early Career Award for Scientists and Engineers (PECASE) 2017 NSF CAREER Award NIH New Innovator Award Forbes' 30 under 30 in Science and Healthcare MIT Technology Review's 35 under 35 Innovators Fellow of Optica, SPIE, and AIMBE Elected to Optica Board of Directors (2025-2027) Professor Hendon maintains an active research program with multiple ongoing grants, as evidenced by her prestigious awards and recent patent issuances. She mentors a diverse group of students across electrical engineering, biomedical engineering, computer science, applied physics, and mechanical engineering disciplines. Her Structure-Function Imaging Laboratory provides students with opportunities to work on clinically relevant technologies from concept through to potential commercialization, with several patents recently issued from laboratory work. The laboratory maintains strong clinical partnerships that provide students with exposure to real-world medical challenges. Professor Hendon's laboratory develops optical imaging platforms that correlate tissue microstructure to electrical conduction and mechanical contraction, with the main clinical driver addressing unmet needs in cardiac electrophysiology. The lab has produced innovative therapeutic catheters and algorithms for improved guidance and monitoring of arrhythmia therapy.

Sara Arenaمشاهده پروفایل

استاد

• Biomechanics
• Cooperative Learning Strategies
• Problem-Based Learning
• +۷ مورد دیگر

Sara Arena is a Collegiate Professor in the Department of Biomedical Engineering and Mechanics at Virginia Tech , where she also serves as Associate Department Head for Curriculum and Course Coordination . Her work spans biomechanics research and innovative engineering education methods. Education: Ph.D., M.S., and B.S. from Virginia Tech Research Interests: Focus on human movement biomechanics, particularly balance recovery and postural stability, combined with educational research emphasizing cooperative and problem-based learning strategies in engineering education. Current projects include modeling human movement dynamics and improving remote teaching methodologies. Scientific Awards: Leader in Teaching, BEAM (2019, 2023) National Defense Science and Engineering Graduate Fellowship (2008-2011) Panelist for NSF and Department of Defense Key Contributions: Developed novel methods for assessing landing kinematics outside laboratory settings, explored friction requirements in aging populations, and pioneered virtual conferencing tools for problem-based learning. Her work has been published in journals like Annals of Biomedical Engineering and Applied Ergonomics . Collaborations: Partnered with institutions including Virginia Tech, American Society of Engineering Education, and multidisciplinary teams focused on biomedical engineering education and clinical biomechanics.

Vahé Nerguizianمشاهده پروفایل

استاد

• Telecommunications
• Bioengineering
• Cancer Cell Detection
• +۸ مورد دیگر

Vahé Nerguizian is a full Professor in the Department of Electrical Engineering at École de technologie supérieure (ÉTS) in Montreal, Canada, where he has established himself as a leading researcher in microelectronics, MEMS, and biomedical applications. Affiliated with the LACIME (Communications and Microelectronic Integration Laboratory), his work bridges engineering disciplines with healthcare innovations, particularly in cancer research and point-of-care diagnostics. His educational background includes a B.Ing. from Polytechnique Montréal, an M.Eng. from McGill University, and a Ph.D. from Concordia University. This strong foundation in electrical engineering has enabled his interdisciplinary research across multiple domains. Nerguizian's research focuses on the intersection of microfluidics, MEMS, and biomedical applications, with particular emphasis on cancer cell detection, liposome production for drug delivery, and microelectronic integration for healthcare solutions. His laboratory develops microfluidic devices for synthesizing nanoparticles and liposomes, with applications in cancer therapeutics and diagnostics. The work combines microwave engineering, bio-MEMS, and microelectronics to create innovative diagnostic tools and therapeutic delivery systems. His recent publications (2021-2025) demonstrate a clear trajectory toward increasingly sophisticated biomedical applications of microfluidic and MEMS technologies, with growing emphasis on cancer research, extracellular vesicle analysis, and therapeutic delivery systems. The research has evolved from fundamental MEMS and microwave engineering toward highly translational biomedical applications. 2015: Excellence in Teaching Award from the Board of Directors Nerguizian has supervised over 25 graduate students across doctoral and master's programs, with current projects focusing on microfluidic systems for nanoparticle synthesis and sensor systems for biomolecule detection. His research has received significant funding through collaborations with medical researchers, particularly with Julia Burnier's team at McGill University. The LACIME laboratory, where he conducts his research, provides state-of-the-art facilities for micro- and nanofabrication, integrated circuit design, and photonic microsystems. As part of the LACIME research group, Nerguizian contributes to a dynamic environment focused on both fundamental and applied research with strong industry connections. The laboratory's work spans from materials science to communication protocols, with particular strength in developing innovative solutions for healthcare applications.

Brian Schmitمشاهده پروفایل

استاد

• Spinal Cord Injury
• Neurorehabilitation
• Human Neurophysiology
• +۳ مورد دیگر

Dr. Brian Schmit is a Professor and Hammes Family Chair in the Joint Department of Biomedical Engineering at Marquette University and Medical College of Wisconsin (MCW). He serves as Associate Dean of Research for the department, Professor in the MCW Department of Physical Medicine & Rehabilitation, and Professor and Director of the MCW Clinical & Translational Science Institute. His work integrates engineering principles with clinical applications to advance neurorehabilitation. Dr. Schmit received his educational training at prestigious institutions: Ph.D. in Biomedical Engineering from Case Western Reserve University (1995) M.S. in Biomedical Engineering from Case Western Reserve University (1992) B.S. in Biomedical Engineering from Marquette University (1988) Dr. Schmit's research focuses on Spinal Cord Injury, Neurorehabilitation, Human Neurophysiology, and Biomechanics . His work explores neural control of movement, develops rehabilitation technologies, and examines biomechanical aspects of gait and balance in patients with spinal cord injury, stroke, and multiple sclerosis. He integrates advanced technologies such as virtual reality, neuroimaging, and electrophysiological techniques to develop innovative rehabilitation approaches. His laboratory environment fosters collaboration between engineers, clinicians, and scientists to translate research findings into clinical practice. Analysis of Dr. Schmit's recent publications reveals a strong emphasis on neurorehabilitation technologies , particularly virtual reality applications for hand dexterity recovery after cervical myelopathy surgery. His work prominently features balance and gait analysis in multiple sclerosis and spinal cord injury populations, with studies examining whole body angular momentum and reactive balance adaptations. Significant research efforts focus on stroke rehabilitation , investigating cortical activity during finger movements and muscle oxygenation in chronic stroke survivors. His scholarly output demonstrates a consistent trajectory toward developing evidence-based, technology-enhanced rehabilitation protocols with strong clinical translation potential. Dr. Schmit has secured substantial research funding: National Institutes of Health grant as Principal Investigator for "High-Intensity, dynamic-stability gait training in people with multiple sclerosis" (September 2022–June 2027) Advancing a Healthier Wisconsin Endowment grant as Principal Investigator for "Virtual reality training paradigm to rehabilitate hand dexterity in degenerative cervical myelopathy" (July 1, 2022–June 30, 2024) National Institutes of Health grant as Co-PI for "High-density surface EMG based CMAP scan for motor unit number estimation" (July 1, 2021—September 30, 2022) National Institutes of Health grant as Co-Investigator for "Locomotion Recovery and Compensation Post-Stroke" (June 2021–May 2026) Dr. Schmit directs the Integrative Neural Engineering & Rehabilitation Laboratory (INERL) , which focuses on understanding neural control of movement and developing engineering solutions for neurorehabilitation. He also serves as Co-Director of the Falk Center for Neurorehabilitation Engineering Research , where interdisciplinary teams work to advance rehabilitation technologies and protocols. His leadership extends to teaching courses such as BIEN 3300 Signals & Systems for Biomedical Engineering, BIEN 6610 Rehabilitative Biosystems, and BIEN 6931 Topics in Biomedical Engineering.

Julie G. Allicksonمشاهده پروفایل

دانشیار

• Regenerative Medicine
• Cell Therapy
• Tissue Engineering
• +۴ مورد دیگر

Julie G. Allickson, Ph.D., serves as Associate Professor of Regenerative Medicine at Mayo Clinic College of Medicine and Science. She holds multiple leadership roles including Consultant in the Division of Transfusion Medicine within the Department of Laboratory Medicine and Pathology, and Director of the Mayo Clinic Center for Regenerative Medicine. Dr. Allickson also serves as the Otto Bremer Trust Director of Biomanufacturing and Product Development for the Center for Regenerative Biotherapeutics (2021-present) and previously held the position of Michael S. and Mary Sue Shannon Family Director of the Center for Regenerative Biotherapeutics (2021-2024). Dr. Allickson joined Mayo Clinic from Wake Forest Institute for Regenerative Medicine where she was Chief Manufacturing Development Center Officer. With over 25 years of experience in clinical translation of cellular therapies and regenerative medicine products, she brings extensive expertise in regulatory affairs, strategic planning, project management, and team building to her role. Her research interests focus on addressing unmet patient needs, particularly for top-of-the-pyramid care, executing biomanufacturing strategies for novel cures, engaging with industry to commercialize discoveries, and facilitating translation of regenerative medicine products including cell therapy, tissue engineering, biomaterials, and devices. Dr. Allickson promotes collaboration with Mayo Clinic's Department of Laboratory Medicine and Pathology, Center for Individualized Medicine, and Comprehensive Cancer Center to develop and deliver regenerative biotherapies. Dr. Allickson's publication record demonstrates consistent contributions to regenerative medicine, with recent work focusing on biomanufacturing capacity, stem cell therapy development, and clinical translation of regenerative technologies. Her research portfolio spans from fundamental stem cell biology to clinical applications, with particular emphasis on mesenchymal stromal cells, pluripotent stem cell therapies, and manufacturing considerations for clinical applications. Vice chair, Cord Blood Association Quality Standards Committee (2017-present) Scientific advisor, Regenerative Outcomes Foundation (2016-present) Editorial board, CellR4 (2015-present) Technical advisory board, Tissue Engineered Products, International Council for Commonality in Blood Banking Automation (2015-present) International Society for Cell and Gene Therapy: Commercialization Committee (2014-present), Founding member (1992-present) American Association of Blood Banks: Member (1989-present), Board of directors (2016-2020) Dr. Allickson has directed enterprise-wide biomanufacturing strategy at Mayo Clinic with the goal of introducing new regenerative therapeutics into clinical practice, particularly for rare and complex conditions requiring specialized, best-in-class care. Her work focuses on making new regenerative treatments available to patients worldwide, including those in underserved communities, through strategic alliances with academia, industry, and government agencies.

Marie-Christine Danielمشاهده پروفایل

دانشیار

• Nanoparticle drug delivery systems
• Gold nanoparticles
• Cancer chemotherapy
• +۵ مورد دیگر

Marie-Christine Daniel serves as an Associate Professor in the Department of Chemistry & Biochemistry at the University of Maryland, Baltimore County (UMBC). Her research laboratory focuses on the preparation of multifunctional colloidal inorganic nanoparticles for medical, materials, and environmental applications. She maintains an active research program with laboratory space in the Meyerhoff Chemistry/Biochemistry Building. Daniel earned her Ph.D. from the University of Bordeaux 1 (France) in 2003, followed by postdoctoral training at Tokyo University (Japan) and Indiana University (IN) in 2004. Her educational background provides a strong foundation in both European and American research traditions. Her primary research interests include the development of nanoparticle-based drug delivery systems for cancer chemotherapy, particularly using dendronized gold nanoparticles capable of carrying payloads of up to 1400 dendrons per nanoparticle. She also investigates plasmon-exciton coupling using gold nanoparticles and quantum dots for quantum computing applications, and develops microfluidic sensors for lead detection in tap water. Her work bridges chemistry, materials science, and biomedical engineering. Analysis of her publication record reveals consistent research output across three main thrusts: 1) Cancer nanomedicine with emphasis on prostate cancer treatment, 2) Quantum phenomena in nanoparticle assemblies, and 3) Environmental sensing applications. Her most recent work (2025) continues to advance quantum dot transfer techniques, while her highly cited 2004 Chemical Reviews article on gold nanoparticles remains influential in the field. Daniel leads multiple funded research projects including NSF-funded work on hyperthermia for enhanced nanoparticle delivery to tumors, development of HIFU (High-intensity focused ultrasound) energized functionalized nanoparticles for tumor ablation, controlled assembly of inorganic nanoparticles for hybrid nanomaterials, and gold nanoparticle-based microfluidic devices for lead sensing in tap water. Her laboratory collaborates extensively with researchers across disciplines including physics, oncology, and engineering. The Daniel Lab maintains active collaborations with the Pelton research group in Physics at UMBC for nanoparticle optical properties research, and works with medical researchers on cancer treatment applications. Current projects include optimizing dendronized gold nanoparticles for prostate cancer treatment, developing gold nanorattles for combination chemotherapy and photothermal therapy, and creating user-friendly lead detection devices for home water testing.

Ahsan Ul Haq Qurashiمشاهده پروفایل

دانشیار

• Materials Science
• Nanotechnology
• Clean Energy
• +۴ مورد دیگر

Dr. Ahsan Ul Haq Qurashi serves as an Associate Professor in the Department of Chemistry at Khalifa University, UAE, having joined in 2019 after nine years at King Fahd University of Petroleum and Minerals (KFUPM) in Saudi Arabia where he was promoted from Assistant Professor (2010-2016) to Associate Professor (2016-2019). Education: PhD, Chonbuk National University, Jeonju, South Korea (2008) MSc in Organic Chemistry, Pune University, Pune, India (2004) Post-doctoral work at Toyama University, Japan under the Venture Business Laboratory program Research Interests: Dr. Qurashi's work focuses on synthesizing functional nanomaterials from earth-abundant metals, oxides, and chalcogenides for strategic applications. His group develops carbon-based materials, porous structures, nanoclusters, and 2D graphene analogues to address clean energy generation/storage, catalysis, and biomedical challenges. Key methodologies include FESEM, HRTEM, XPS, and Raman spectroscopy for structure-property analysis. Professional Roles: He is a subject editor for the International Journal of Hydrogen Energy (currently on sabbatical) and serves on the editorial boards of Materials Research Bulletin and Scientific Reports. Dr. Qurashi has supervised undergraduate, M.S., and PhD students in materials chemistry research. Research Affiliation: His work is conducted through the Center for Catalysis and Separation Research, targeting hydrogen production via electrolysis, CO 2 conversion to clean fuels, energy storage systems, ammonia synthesis, corrosion mitigation, and biomedical applications.

Gil Westmeyerمشاهده پروفایل

استاد

• Molecular Sensors
• Molecular Actuators
• Neuroimaging
• +۷ مورد دیگر

Prof. Dr. Gil Westmeyer is a Professor of Neurobiological Engineering at the Technical University of Munich (TUM), holding joint appointments at the TUM School of Natural Sciences and TUM School of Medicine and Health. He serves as Director of the Institute for Synthetic Biomedicine at Helmholtz-Zentrum München and leads the Chair of Neurobiological Engineering at TUM. His research program bridges molecular engineering, neuroimaging, and synthetic biology to develop next-generation tools for understanding and manipulating cellular networks. Westmeyer's educational background includes medical and philosophical studies in Munich, doctoral work on the molecular basis of Alzheimer's disease under Professor Christian Haass, clinical training at Harvard Medical School, and postdoctoral research with Professor Alan Jasanoff at MIT. His laboratory focuses on creating genetically encoded molecular sensors and actuators that enable non-invasive imaging and remote control of cellular processes across multiple scales. His research spans three primary domains: molecular sensors for multimodal imaging (from electron microscopy to whole-organism optoacoustics), molecular actuators for spatiotemporal control of cellular processes, and neurobehavioral imaging in freely behaving model organisms. The lab's work integrates synthetic biology, nanotechnology, and advanced imaging techniques to create tools that map dynamic signaling processes and manipulate cellular functions with unprecedented precision. Westmeyer's publication record demonstrates consistent innovation in molecular engineering, with recent work focusing on genetically encoded barcodes for electron microscopy, intron-encoded reporting systems, multiplexed optoacoustic imaging, and magnetically responsive cellular compartments. His publications in high-impact journals like Nature Methods, Cell, and Nature Biotechnology reflect the significance of his contributions to molecular imaging and engineering. ERC Proof of Concept 'inteRNAlizer' (2023) ERC Consolidator Grant 'EMcapsulins' (2019) ERC Starting Grant 'MagnetoGenetics' (2013) Helmholtz Young Investigator's Group (2011) Westmeyer actively mentors students and researchers through multiple teaching positions at TUM, including courses in biological chemistry, genetic machine development (iGEM), mammalian cell technology, and neuro-recording methods. His laboratory develops technologies with clear translational potential for future neurotherapies and regenerative medicine applications, particularly through the creation of imaging-controlled cellular interventions. The lab maintains strong collaborations across disciplines and institutions, with research that contributes to multiple UN Sustainable Development Goals related to health and wellbeing.

• Biomedical Engineering
• Stem Cell Research
• Nanotechnology
• +۶ مورد دیگر

Professor Stuart Reid FRSE serves as Head of Department and Royal Society Industry Fellow in Biomedical Engineering at the University of Strathclyde. He leads a multidisciplinary research team working at the intersection of medical science and advanced physics, with significant contributions to both regenerative medicine and gravitational wave detection technologies. His research encompasses two major thrusts: Nanokicking Technology: As co-inventor of 'nanokicking,' he developed a method using precisely controlled nanoscale vibrations to stimulate stem cells to differentiate into bone tissue. This groundbreaking work, published in ACS Nano (2013) and Nature Biomedical Engineering (2017), is now being translated to clinical applications through nanokick.com, with support from Find A Better Way charity for land mine injury treatment. Advanced Optical Coatings: His laboratory has pioneered the world's first high-energy ECR ion beam deposition facility, producing the lowest absorption sputtered amorphous silicon coatings (PRL 2018) for next-generation gravitational wave detectors. This work enables detectors to approach quantum noise limitations. Professor Reid's publications reveal a consistent trajectory from fundamental science to clinical and industrial applications, demonstrating exceptional translational impact across disciplines. His recent work increasingly focuses on commercialization and clinical translation of both nanokicking technology and advanced optical coatings. His scientific recognition includes: Appointment to the RSE Young Academy of Scotland (2014) Membership on the Royal Society's Research Grants Board (2020) 12 total prizes as documented in his academic profile Currently overseeing 49 research projects (16 active, 33 completed), Professor Reid directs significant research funding including the BIOME project (2025-2026) and EPSRC DTP research on extracellular vesicles. He established the Extreme Performance Optical Coatings testbed (www.epoc.scot) within the National Manufacturing Institute Scotland, creating a national resource for advanced optical coating development and testing.

Ben Z. Stangerمشاهده پروفایل

استاد

• Pancreatic Cancer
• Cellular Plasticity
• Tumor Immunology
• +۳ مورد دیگر

Ben Z. Stanger, M.D., Ph.D. is the Hanna Wise Professor in Cancer Research at the University of Pennsylvania's Perelman School of Medicine, with appointments in the Department of Medicine and Cell and Developmental Biology. He serves as Director of the Penn Pancreatic Cancer Research Center (PCRC) and is an active member of the Abramson Cancer Center, Institute for Diabetes, Obesity and Metabolism, Institute for Medicine and Engineering, and Institute for Regenerative Medicine. His laboratory is housed in the Biomedical Research Building II/III on the Penn campus in Philadelphia. Education: SB (Life Sciences) from Massachusetts Institute of Technology, 1988 MD and PhD (Genetics) from Harvard Medical School, 1997 Dr. Stanger's research focuses on pancreatic ductal adenocarcinoma (PDAC), which is poised to become the second leading cause of cancer death in the United States. His laboratory investigates how pancreatic tumors metastasize early in disease progression and identifies therapeutic vulnerabilities through studies of the tumor microenvironment, metabolism, cellular plasticity, and metastasis biology. His team employs genetically engineered mouse models that recapitulate human disease features, functional genomics, epigenetic analyses, and advanced in vitro culture systems. Analysis of Dr. Stanger's recent publications (2019-2024) reveals a consistent focus on pancreatic cancer biology with increasing emphasis on tumor immunology and therapeutic resistance mechanisms. His research has evolved from fundamental studies of tumor-stroma interactions toward more translational investigations of KRAS inhibition, immune microenvironment regulation, and cellular reprogramming in cancer. Recent work demonstrates how tumor plasticity drives resistance to immunotherapy and how metabolic adaptations allow cancer cells to survive nutrient-deprived conditions. Dr. Stanger maintains an active laboratory with diverse personnel including postdoctoral researchers, graduate students, research specialists, and administrative support. His lab has published in high-impact journals including Nature Communications, Cancer Discovery, Cancer Research, and Science. In addition to his research, Dr. Stanger has authored the book "From One Cell: A Journey into Life's Origins and the Future of Medicine" which explores embryonic development through the lens of scientific history. Research Team: Principal Investigator: Ben Stanger, MD, PhD Research Specialists: Chenghua Yang (Lab Manager), Lily Watson (Assistant Lab Manager) Research Coordinator: Sean O'Connor Postdoctoral Researchers: Austin Good, Cole Edwards, Feiyan Mo, Minh Than Graduate/Post-Graduate Students: Erin Hollander, Benjamin Kahn, Jayne McDevitt, Margo Orlen, William Sullivan, Jane Xie Undergraduate Researcher: Shreya Nair Executive Administrator: Fran Tucker

Sandra Calkinsمشاهده پروفایل

استادیار

• Social and Cultural Anthropology
• Science and Technology Studies (STS)
• Medical Anthropology
• +۷ مورد دیگر

Sandra Calkins is Assistant Professor of Social and Cultural Anthropology at the Free University of Berlin and a member of the LOST research network hosted at the University of Halle. Her work integrates science and technology studies with medical anthropology to interrogate how evidence about global health interventions is produced, circulated, and contested. Education PhD, Anthropology – Leipzig University (2014) M.A., Anthropology – Leipzig University (2008) Research Interests Drawing on pragmatism and STS, Calkins examines how material-semiotic assemblages shape social orderings and public health problem definitions. Her current project, "Better Bananas for Ugandans," investigates biofortification as a high-tech agricultural fix for micronutrient deficiencies. Through ethnographic fieldwork in Uganda and Australia, she traces how human bodies, banana plants, transgenes, and funding agencies are enrolled into experimental regimes that produce evidence of efficacy and safety. She is particularly concerned with: Infrastructures of evidence and their global politics Agenda-setting in public health nutrition Tensions between emerging biological paradigms (e.g., epigenetics) and established biomedical truths The affective and temporal dimensions of scientific work in post-colonial settings Publication Trends Calkins’s recent output (2019-2021) clusters around three thematic nodes: (1) ethnographies of laboratory and field science in Uganda, (2) critical analyses of evidence and valuation in global health, and (3) theoretical contributions to STS and medical anthropology. Collectively, these works advance a more-than-human anthropology that foregrounds plants, chemicals, and infrastructures as co-constitutive actors in technoscientific worlds. Scientific Awards No specific awards or fellowships are listed in the provided material. Research Funding & Teams Her research has been supported through the collaborative LOST program (Law, Organization, Science and Technology). She has conducted extensive ethnographic fieldwork since 2015 at the National Agricultural Research Laboratories in Kawanda, Uganda, working alongside plant breeders, molecular biologists, nutritionists, and local farming communities.

Axel Rosenhahnمشاهده پروفایل

استاد

• Surface Chemistry
• Bio-Interfacial Chemistry
• Antifouling Coatings
• +۳ مورد دیگر

Professor Axel Rosenhahn serves in the Department of Analytical Chemistry at Ruhr University Bochum's Faculty of Chemistry and Biochemistry. His research group develops environmentally friendly antifouling and biomedical coatings through investigations of microorganism and cell interactions with polymeric materials. His research focuses on surface colonization dynamics using advanced techniques including microfluidic assays, 3D tracking, and X-ray nanoanalysis. Key areas include bio-interfacial phenomena, environmentally sustainable coating technologies, and biomaterial characterization. His work bridges analytical chemistry with biological applications through the Biointerfaces research group. Professor Rosenhahn maintains active laboratory facilities at the university's research infrastructure including ZEMOS (Centre for Molecular Spectroscopy and Simulation of Solvent-Driven Processes) and collaborates within RESOLV, the Cluster of Excellence for Solvation Science. His research group operates from room NC 4/27 with direct contact available via university channels.

Zhang Yangمشاهده پروفایل

دانشیار

• Artificial Intelligence in Biomedical Imaging
• Deep Learning for Omics Data Analysis
• Pathogen Detection and Diagnostics
• +۷ مورد دیگر

Zhang Yang is an Associate Professor at the School of Medical Engineering, Harbin Institute of Technology (Shenzhen), with a joint appointment as Visiting Professor at the University of Tokyo starting in July 2024. He holds a PhD from the University of Cambridge's Department of Pathology and an M.Phil. from the University of Hong Kong's HKU-Pasteur Research Center. Previously, he served as an Assistant Professor at Harbin Institute of Technology (Shenzhen) from September 2015 to December 2020. His research integrates computational and experimental approaches to address challenges in pathogen and cancer research. On the computational side, his work focuses on developing AI-powered microscopic imaging systems, applying deep learning to analyze multi-omics data (including proteins, DNA, miRNAs, LncRNAs, and mRNAs), and utilizing deep learning in cheminformatics for drug discovery. On the experimental side, his laboratory combines imaging, high-throughput sequencing, mass spectrometry, and chemical biology to understand disease mechanisms at the molecular level. His publication record demonstrates significant impact, with over 50 SCI-indexed papers in high-impact journals including Nature Communications, Briefings in Bioinformatics, Bioinformatics, Analytical Chemistry, and Trends in Biotechnology. His work has been cited by prestigious journals such as Nature Reviews Methods Primers and Nature Communications, with three ESI highly cited papers. His research spans multiple interdisciplinary fields, combining artificial intelligence with biomedical applications to advance diagnostic and therapeutic approaches. World's Top 2% Scientists 2021 Fellow of the Royal Society of Biology Three ESI Highly Cited Papers Five authorized national invention patents As an academic leader, he serves as Associate Editor for BMC Biology and Frontiers in Microbiology, Academic Editor for PLOS Genetics, Editorial Board Member for Communications Biology, and Guest Editor for a Special Issue on AI in analytical chemistry in Trends in Analytical Chemistry. His laboratory actively collaborates with international institutions, with graduates pursuing further studies at Hong Kong Chinese University, Hong Kong University of Science and Technology, Hong Kong Polytechnic University, Macau University, and the University of New South Wales. He teaches Introduction to Modern Biology for undergraduates and Bioanalytical Chemistry for graduate students.

Aly Karsanمشاهده پروفایل

استاد

• Leukemia
• Hematopoiesis
• Genomics
• +۸ مورد دیگر

Aly Karsan is a Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia (UBC) and a Distinguished Scientist at Canada’s Michael Smith Genome Sciences Centre at BC Cancer. His research focuses on the molecular basis of myeloid leukemias, aging-related cancer resistance, and clinical genomics innovation. Affiliations: Faculty of Medicine (UBC), School of Biomedical Engineering (UBC), BC Cancer Research Institute, Centre for Blood Research (UBC) Clinical leadership: Established first clinically-accredited Next-Generation Sequencing lab in Canada Research Interests Dr. Karsan investigates: Genomic and epigenomic aberrations in aging-related leukemia Role of noncoding RNAs and innate immune signaling in blood cancers Embryonic blood stem cell emergence via Sash1 signaling Clonal interactions in acute myeloid leukemia (AML) Mechanisms of lenalidomide resistance in myelodysplastic syndromes Scientific Contributions Recent publications demonstrate expertise in: NGS technology validation Genetic barcoding systems TGFβ signaling in hematopoiesis Bayesian network diagnostics Awards & Recognition Tier 1 Canada Research Chair in Blood Cancers John Auston BC Cancer Foundation Clinical Scientist Award Health Employers Association of BC Gold Apple Award for Innovation Multiple CIHR Clinician-Scientist and MSFHR Scholar awards Labs & Collaborations Leads the Karsan Lab at BC Cancer Research Institute and coordinates a Terry Fox Research Institute Program Project with six principal investigators.

Jay Bertran-Gonzalezمشاهده پروفایل

دانشیار

• Neuroscience
• Behavioral Neuroscience
• Striatal Circuitry
• +۶ مورد دیگر

Associate Professor Jay Bertran-Gonzalez is a faculty member in the School of Psychology at The University of New South Wales (UNSW), where he serves as Director of the Australasian Course in Advanced Neuroscience (ACAN) and Deputy Director of the Decision Neuroscience Laboratory. His work focuses on neuromodulatory systems, striatal circuits, and goal-directed behavior, with particular interests in aging, synaptic plasticity, and dopamine/cholinergic signaling. Education: PhD in Biomedical Research (Université Pierre et Marie Curie, 2010); Master of Biomedical Research (INSERM, 2007); Graduation Project (Universitat Pompeu Fabra, 2006). His research explores how striatal circuits integrate neuromodulatory signals to control action selection, aging-related cognitive decline, and molecular mechanisms of neuroplasticity. Recent work examines lipid signaling in memory and cortico-basal ganglia interactions in behavioral adaptation. Key trends in his 15 most recent articles include striatal neuroplasticity, aging and cognition, GPCR-mediated memory processes, and dopamine-cholinergic interneuron interactions. Collaborative networks span institutions like QBI, Columbia University, and the University of Geneva. Scientific Awards: ARC DECRA (2016), UNSW Dean of Science Early Career Award (2020), Goldstar Award (2018), and more. He has secured significant grants, including NHMRC Ideas Grants (2024, 2023) and ARC Future Fellowship (2021-2024). He teaches NEUR3221 Neurophysiology and PSYC4103, and coordinates ACAN's Systems Neuroscience & Behaviour Theme. As Head of the Neuromodulatory Systems & Behaviour Team and a member of the Australasian Neuroscience Society Council, he bridges research, education, and cross-institutional collaboration.